Stocktoria
Guardant Health, Inc. GH
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2018-10-04
Guardant Health, Inc. statistics & valuation
Market cap$19.8B
P / S20.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -44.5% | -60.0% | -100.1% | -121.1% | -110.0% |
| Net margin | -42.4% | -59.0% | -85.0% | -145.6% | -103.0% |
| FCF margin | -23.7% | -37.2% | -61.3% | -86.1% | -76.0% |
| Return on assets | -20.7% | -29.4% | -26.8% | -40.7% | -17.5% |
| Return on equity | 419.2% | 312.5% | -302.1% | -1087.7% | -59.7% |
| Debt / equity | -15.14× | -8.18× | — | — | — |
| Current ratio | 4.84 | 4.68 | 6.54 | 6.17 | 5.72 |
| Revenue growth | 32.9% | 31.0% | 25.5% | 20.3% | 30.3% |
Source: SEC EDGAR filings · CIK 0001576280 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.